Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.
South Africa shows one of the highest global burdens of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). Since 2002, MDR-TB in South Africa has been treated by a standardized combination therapy, which until 2010 included ofloxacin, kanamycin, ethionamide, ethambutol...
Main Authors: | Borna Müller, Violet N Chihota, Manormoney Pillay, Marisa Klopper, Elizabeth M Streicher, Gerrit Coetzee, Andre Trollip, Cindy Hayes, Marlein E Bosman, Nicolaas C Gey van Pittius, Thomas C Victor, Sebastien Gagneux, Paul D van Helden, Robin M Warren |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3751934?pdf=render |
Similar Items
-
Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa
by: Marisa Klopper, et al.
Published: (2013-03-01) -
Programmatic challenges in managing multidrug-resistant tuberculosis in Malawi
by: Loveness Charlie, et al.
Published: (2021-01-01) -
The mycosins, a family of secreted subtilisin-like serine proteases associated with the immunologically-important ESAT-6 gene clusters of Mycobacterium tuberculosis
by: Gey van Pittius, Nicolaas Claudius
Published: (2012) -
Characterization of Mycobacterium orygis
by: Nicolaas C. Gey van Pittius, et al.
Published: (2012-10-01) -
The non-clonality of drug resistance in Beijing-genotype isolates of <it>Mycobacterium tuberculosis </it>from the Western Cape of South Africa
by: Van Helden Paul D, et al.
Published: (2010-11-01)